# RSV
Store analysis performed in the context of RSV mass vaccination in the US. 

On data lock point of 27 Oct 2023:  
* [Safety Competitive Analysis Arexvy vs Abrysvo](https://ospv.github.io/2023_10_27 - Safety Competitive Analysis - Arexvy vs Abrysvo.html)
* [Exposure during pregnancy post Arexvy](https://ospv.github.io/RSV/2023_10_27_SignalEval_Pregnancy_exposure.html)
